Products and services in the pipeline from Nymox Pharmaceuticals Corp.; OncoGenex Pharmaceuticals, Inc.; Ampio Pharmaceuticals, Inc.; Aragon Pharmaceuticals; Sophiris Bio Inc.; Genomic Health, Inc.; OxThera AB; Aeterna Zentaris Inc.; and Tengion, Inc.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.